Purified anti-human CD3 Antibody

Pricing & Availability
Clone
OKT3 (See other available formats)
Regulatory Status
RUO
Workshop
HCDM listed
Other Names
T3, CD3ε
Isotype
Mouse IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
OKT3_Purified_053107
Human peripheral blood lymphocytes stained with purified OKT3, followed by anti-mouse IgGs-FITC
  • OKT3_Purified_053107
    Human peripheral blood lymphocytes stained with purified OKT3, followed by anti-mouse IgGs-FITC
Cat # Size Price Save
317301 25 µg ¥5,000
317302 100 µg ¥10,000
Description

CD3ε is a 20 kD chain of the CD3/T cell receptor (TCR) complex, which is composed of two CD3ε, one CD3γ, one CD3δ, one CD3ζ (CD247), and a T cell receptor (α/β or γ/δ) heterodimer. It is found on all mature T lymphocytes, NK T cells, and some thymocytes. CD3, also known as T3, is a member of the immunoglobulin superfamily that plays a role in antigen recognition, signal transduction, and T cell activation.

Product Details
Technical data sheet

Product Details

Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC-F - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

The OKT3 monoclonal antibody reacts with an epitope on the epsilon-subunit within the human CD3 complex.

Clone OKT3 can block the binding of clones SK7 and UCHT1.4 The OKT3 antibody is able to induce T cell activation. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections and activation of T cells. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 317304). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 317326) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Knapp W. 1989. Leucocyte Typing IV. Oxford University Press New York.
  3. Barclay N, et al. 1997. The Leucocyte Antigen Facts Book. Academic Press Inc. San Diego.
  4. Li B, et al. 2005. Immunology 116:487.
  5. Jeong HY, et al. 2008. J. Leuckocyte Biol. 83:755. PubMed
  6. Alter G, et al. 2008. J. Virol. 82:9668. PubMed
  7. Manevich-Mendelson E, et al. 2009. Blood 114:2344. PubMed
  8. Pinto JP, et al. 2010. Immunology. 130:217. PubMed
  9. Biggs MJ, et al. 2011. J. R. Soc. Interface. 8:1462. PubMed
Product Citations
  1. Pinto J, et al. 2010. Immunology. 130:217. PubMed
  2. Blas-Rus N, et al. 2016. Nat Commun. 7: 11389. PubMed
  3. Barzilai S, et al. 2017. Cell Rep. 18(3):685-699. PubMed
  4. Welch JL, et al. 2020. FEBS Lett. 594:695. PubMed
  5. Zavidij O, et al. 2020. Nat Cancer. 0.384027778. PubMed
  6. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  7. Hu X, et al. 2021. British Journal of Pharmacology. 178(6):1445-1458. PubMed
  8. He Y, et al. 2021. eLife. 10:00. PubMed
  9. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  10. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
  11. Kaufmann M, et al. 2021. Med. 2(3):296-312.e8. PubMed
  12. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  13. Henrick BM, et al. 2021. Cell. . PubMed
  14. Winkler M, et al. 2017. PLoS One.. 10.1371/journal.pone.0182427. PubMed
  15. Qiu H, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.08.036. PubMed
  16. Lang C, Wang J, and Chen L 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.09.030. PubMed
  17. Thomi R, et al. 2017. Br J Dermatol.. 10.1111/bjd.15458. PubMed
  18. Jin Y, et al. 2017. Int Immunopharmacol. . 10.1016/j.intimp.2017.10.009. PubMed
  19. Pawlak EN, et al. 2018. Retrovirology. 15:6. PubMed
  20. Yarzabek B et al. 2018. eLife. 7 pii: e34961. PubMed
  21. Broos K, et al. 2019. Cancers (Basel). 11. PubMed
  22. Xiong Y, et al. 2019. J Immunol. 203:3023. PubMed
  23. Dutertre CA, et al. 2020. Immunity. 51(3):573-589.e8.. PubMed
  24. Alcántara‐Hernández M et al. 2017. Immunity. 47(6):1037-1050 . PubMed
  25. Nissim L et al. 2017. Cell. 171(5):1138-1150 . PubMed
  26. Schoknecht T, et al. 2017. J Leukoc Biol. 101:589. PubMed
  27. Crome SQ, et al. 2017. Nat Med. 1.213888889. PubMed
  28. Kessel C, et al. 2017. Arthritis Rheumatol. 69:1480. PubMed
  29. Singh AK, et al. 2017. Front Immunol. 0.513888889. PubMed
  30. García–Ortiz A, et al. 2017. PLoS Biol. 15:e2000653. PubMed
  31. Liu Z, et al. 2017. Oncotarget. 8:53518. PubMed
  32. Horn LA, et al. 2017. Oncotarget. 8:57964. PubMed
  33. Johnston HE, et al. 2018. Mol Cell Proteomics. 1.247222222. PubMed
  34. Bae EA, et al. 2018. Cancer Res. 78:5315. PubMed
  35. Meng Q, et al. 2018. Sci Rep. 8:17079. PubMed
  36. Mayer KE, et al. 2019. Theranostics. 4.548611111. PubMed
  37. Escudero–Pérez B, et al. 2019. JCI Insight. 4:e126070. PubMed
  38. Terzuoli E, et al. 2019. Cancers (Basel). 1.821527778. PubMed
  39. Sneddon S, et al. 2020. Oncoimmunology. 9:1684713. PubMed
  40. Seo N, et al. 2018. Nat Commun. 9:435. PubMed
  41. Liang J, et al. 2017. Nat Commun. 8:15732. PubMed
  42. Auladell M, et al. 2019. Clin Transl Immunology. 8:e01090. PubMed
  43. Ardain A, et al. 2019. Nature. 570:528. PubMed
  44. Boutboul D, et al. 2018. J Clin Invest. 128:3071. PubMed
  45. Bluhm J, et al. 2018. Mol Ther. 26:1906. PubMed
  46. Holbrook AK, et al. 2019. Physiol Rep. 7:e14234. PubMed
  47. Caielli S, et al. 2019. Nat Med. 25:75. PubMed
  48. Chevalier MF, et al. 2017. J Clin Invest. 127:2916. PubMed
  49. Benabdallah B, et al. 2019. Front Immunol. 10:2580. PubMed
  50. Hashimoto M, et al. 2017. Int J Inflam. 2017:1324735. PubMed
  51. Yin Y, et al. 2017. J Allergy Clin Immunol. 139:1701. PubMed
  52. Willing A, et al. 2018. J Immunol. 200:974. PubMed
  53. Tripathi T, et al. 2019. Immunohorizons. 0.201388889. PubMed
  54. Kujawski M, et al. 2019. BMC Cancer. 1.404166667. PubMed
  55. Ghosh S, et al. 2020. Cell Reports. 30(10):3434-3447. PubMed
  56. Walk J, et al. 2020. Front Immunol. 2.405555556. PubMed
  57. Zhao R, et al. 2018. Oncoimmunology. 8:e1509173. PubMed
  58. Mehta N, et al. 2020. Sci Rep. 10:15171. PubMed
  59. Leylek R, et al. 2020. Cell Rep. 32:108180. PubMed
  60. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  61. Mousset CM, et al. 2018. Oncoimmunology. 7:e1488565. PubMed
  62. Siegers GM, et al. 2020. Front Immunol. 1.352083333. PubMed
  63. Alter G, et al. 2008. J Virol. 82:9668. PubMed
  64. Jeong H, et al. 2008. J Leukoc Biol. 83:755. PubMed
  65. Manevich-Mendelson E, et al. 2009. Blood. 114:2344. PubMed
  66. Biggs M, et al. 2011. J R Soc Interface. 1.348611111. PubMed
RRID
AB_571926 (BioLegend Cat. No. 317301)
AB_571927 (BioLegend Cat. No. 317302)

Antigen Details

Structure
Ig superfamily, the subunits CD3γ, CD3δ, CD3ζ (CD247) and TCR (α/β or γ/δ) form the CD3/TCR complex, 20 kD
Distribution

Mature T and NK T cells, thymocyte differentiation

Function
Antigen recognition, signal transduction, T cell activation
Ligand/Receptor
Peptide antigen bound to MHC
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References
  1. Barclay N, et al. 1993. The Leucocyte FactsBook. Academic Press. San Diego.
  2. Beverly P, et al. 1981. Eur. J. Immunol. 11:329.
  3. Lanier L, et al. 1986. J. Immunol. 137:2501.
Gene ID
916 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 06/12/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account